Israeli Health Official Discloses Gates Foundation Ties in Polio Vaccine Approval

The ERT committee at Israel’s Ministry of Health was established in March 2022 to manage the response to a polio outbreak detected in sewage testing in Israel. ZeroHedge reported the committee's discussions integrated the WHO's EUL pathway into Israel's decision-making process.

Prof. Schulman's role as secretary of the polio committee involved overseeing discussions on the vaccine's importation. ZeroHedge reported that the committee's early deliberations dealt with poliovirus type 3 originating from a live-attenuated vaccine, showing sensitivity to WHO positions.

In late 2022, the ERT committee voted 14-1, with support from all six Ministry of Health representatives, to bring the nOPV2 vaccine to Israel.

ZeroHedge reported this vote shifted focus to implementation steps for the WHO pathway. The materials indicate the WHO has developed mechanisms like EUL to influence regulatory processes within states, operating as a de facto framework. ZeroHedge reported that EUL is defined as a temporary, risk-based authorization for unapproved products in emergencies, based on partial data.

Dr. David Bell, a former WHO medical officer, noted that once a product receives emergency authorization and is deployed, institutional pressure often leads to full approval despite limitations. ZeroHedge reported this reflects a broader shift in regulatory practice, as seen during Covid-19.

Under the International Health Regulations, a Public Health Emergency of International Concern focuses on international spread without a quantified severity threshold. ZeroHedge reported that flexible emergency criteria lower the threshold for invoking such mechanisms. The nOPV2's trajectory shows progression from EUL to broader endorsement without conventional Western licensure.

ZeroHedge reported Israel served as a test case for embedding this international pathway into a sovereign state's regulatory system. The ERT committee's mandate included formulating vaccination policy and managing public information. ZeroHedge reported discussions from mid-2022 considered nOPV2, linking epidemiological assessment to procedural options.

Presentations and materials from the WHO guided the committee's deliberations on nOPV2 approval. ZeroHedge reported no record of a full manufacturer dossier or independent Western regulatory opinion in the minutes. A 'Two Drops' campaign using an existing OPV3 vaccine ran from April to June 2022, after which type 2 poliovirus was detected in sewage.

ZeroHedge reported no paralysis cases from type 2 have been found in Israel to date. The committee chair, Prof. Manfred Green, heads the International Public Health Leadership Program at the University of Haifa’s School of Public Health.

ZeroHedge reported Schulman previously headed the Central Environmental Virology Laboratory at Sheba Medical Center. Bell described soft power in international health networks, where shared incentives and professional culture align approaches across countries without formal coercion. ZeroHedge reported delegates in such forums often act within a common worldview supported by major funders.